Inspiolto Respimat (tiotropium/olodaterol)

pCPA File Number: 20870

Negotiation Status:

Concluded with an LOI

Indication(s):

Heart failure, NYHA class II

Sponsor/Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

CDA-AMC Project Number:

SR0436-000

pCPA Engagement Letter Issued:

2016-02-22

Negotiation Process Concluded:

2016-03-02